Altimmune, Inc. (ALT)

NASDAQ: ALT · Real-Time Price · USD

6.01

+0.42 (7.51%)

May 12, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Treatments for Various Diseases and Disorders, and Vaccines	20.00K	Log In	Log In	Log In	Log In	Upgrade
Treatments for Various Diseases and Disorders, and Vaccines Growth	-95.31%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
United States	20.00K	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-95.31%	Log In	Log In	Log In	Log In	Upgrade